Form D · Biotechnology
AlmataBio, Inc.
Atlanta, GA · CIK 0002002604
Offering snapshot reported Dec 4, 2023 · SEC filing
- Reported sold
- $2.13M Offering amount: $4M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2023 | Initial | $2,129,502 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498706
The Total Offering Amount and Total Amount Sold includes the conversion of $29,503 in debt securities.
Source: Form D, filed Dec 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick J Crutcher | Director, Executive, Promoter |
| Justin Di Martino | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
650 Ponce De Leon Ave, Ste. 300 #3315
Atlanta, GA, 30308
Atlanta, GA, 30308